Loading clinical trials...
Loading clinical trials...
A Phase 3, Multi-Center, Open Label Study To Evaluate The Long-Term Safety Of Sitaxentan Sodium In Japanese Subjects With Pulmonary Arterial Hypertension
Conditions
Interventions
Sitaxentan
Locations
2
Japan
Pfizer Investigational Site
Nagoya, Aichi-ken, Japan
Pfizer Investigational Site
Shinjyuku-ku, Tokyo, Japan
Start Date
November 1, 2010
Primary Completion Date
December 1, 2010
Completion Date
December 1, 2010
Last Updated
December 14, 2011
NCT07079592
NCT05719415
NCT07039604
NCT03388476
NCT01065454
NCT04732221
Lead Sponsor
Pfizer
Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and Conditions